YouTube as a source of misinformation on COVID-19 vaccination: a systematic analysis

Author:

Li Heidi Oi-YeeORCID,Pastukhova Elena,Brandts-Longtin Olivier,Tan Marcus G,Kirchhof Mark GORCID

Abstract

IntroductionVaccines for SARS-CoV-2 have been accessible to the public since December 2020. However, only 58.3% of Americans are fully vaccinated as of 5 November 2021. Numerous studies have supported YouTube as a source of both reliable and misleading information during the COVID-19 pandemic. Misinformation regarding the safety and efficacy of COVID-19 vaccines has negatively impacted vaccination intent. To date, the literature lacks a systematic evaluation of YouTube’s content on COVID-19 vaccination using validated scoring tools. The objective of this study was to evaluate the accuracy, usability and quality of the most widely viewed YouTube videos on COVID-19 vaccination.MethodsA search on YouTube was performed on 21 July 2021, using keywords ‘COVID-19 vaccine’ on a cleared-cache web browser. Search results were sorted by ‘views’, and the top 150 most-viewed videos were collected and analysed. Duplicate, non-English, non-audiovisual, exceeding 1-hour duration, or videos unrelated to COVID-19 vaccine were excluded. The primary outcome was usability and reliability of videos, analysed using the modified DISCERN (mDISCERN) score, the modifiedJournal of the American Medical Association(mJAMA) score and the COVID-19 Vaccine Score (CVS).ResultsApproximately 11% of YouTube’s most viewed videos on COVID-19 vaccines, accounting for 18 million views, contradicted information from the WHO or the Centers for Disease Control and Prevention. Videos containing non-factual information had significantly lower mDISCERN (p<0.001), mJAMA (p<0.01) and CVS (p<0.001) scores compared with videos with factual information. Videos from government sources had higher mJAMA and CVS scores, but averaged three times the ratio of dislikes to likes, while videos containing non-factual information averaged 14 times more likes than dislikes.ConclusionAs the COVID-19 pandemic evolves, widespread adoption of vaccination is essential in reducing morbidity, mortality, and returning to some semblance of normalcy. Providing high-quality and engaging health information from reputable sources is essential in addressing vaccine hesitancy.

Publisher

BMJ

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference29 articles.

1. World Health Organization . COVID-19 Weekly epidemiological update, 2021. Available: https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19-2-november-2021

2. FDA . FDA approves first COVID-19 vaccine. FDA NEWS release, 2021. Available: https://www.fda.gov/news-events/press-announcements/fda-approves-first-covid-19-vaccine [Accessed 3 Nov 2021].

3. Centers for Disease Control and Prevention . CDC COVID data tracker, 2021. Available: https://covid.cdc.gov/covid-data-tracker/#vaccinations_vacc-people-onedose-pop-12yr [Accessed 5 Nov 2021].

4. Centers for Disease Control and Prevention . Delta variant, 2021. Available: https://www.cdc.gov/coronavirus/2019-ncov/variants/delta-variant.html [Accessed 3 Nov 2021].

5. Model depicting aspects of audit and feedback that impact physicians’ acceptance of clinical performance feedback

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3